Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Price Down 6% – What’s Next?

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) fell 6% during trading on Friday. The stock traded as low as $12.67 and last traded at $12.6850. Approximately 7,950 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 1,110,588 shares. The stock had previously closed at $13.50.

Analysts Set New Price Targets

BAYRY has been the topic of several analyst reports. Zacks Research upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a report on Thursday, July 2nd. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Down 0.5%

The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The business has a 50-day simple moving average of $14.02 and a 200-day simple moving average of $12.51. The stock has a market cap of $49.75 billion, a P/E ratio of -24.82, a PEG ratio of 2.03 and a beta of 0.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.06. The business had revenue of $12.53 billion during the quarter, compared to analysts’ expectations of $12.31 billion. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. Analysts expect that Bayer Aktiengesellschaft will post 1.28 EPS for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a Germany-based life science company focused on health care and agriculture. Through its Pharmaceuticals, Consumer Health and Crop Science businesses, the company develops and markets products intended to improve human health, everyday self-care and agricultural productivity.

Bayer’s Pharmaceuticals business provides prescription medicines in areas such as cardiovascular disease, women’s health, oncology and specialty medicine. Its Consumer Health division offers nonprescription products in categories including pain relief, nutritional supplements, dermatology and allergy care, with brands such as Aspirin and Claritin.